Immunome (IMNM) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Immunome (IMNM) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Immunome

· IMNM

Dashboard

Financials

Ratios

Valuation

Statistics

2.486 B

-1.74%

General

Market Cap: $2.49B
Enterprise Value: $1.84B
Shares Outstanding: 113,250,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -44.98%
ROE: -50.56%
ROIC: -51.06%
Current Ratio: 15.08
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 3.92
EV/EBITDA: -7.34

Growth

Rev 1Y: -23.23%
Rev 1Y Fwd Est: -94.76%
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $220.52M
Operating Income: -$270.47M
Net Profit: -$254.32M

Balance Sheet

Cash and Equivalents: $217.71M
Working Capital: $502.74M
Total Assets: $565.38M
Net Debt: -$213.12M
Total Liabilities: $40.3M
Total Equity: $525.08M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$208.79M
Cash Flow from Investing: -$196.48M
Cash Flow from Financing: $479.11M
Free Cash Flow: -$219.09M
Capital Expenditures: $10.29M